Piramal Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0DK501011
  • NSEID: PPLPHARMA
  • BSEID: 543635
INR
179.85
-3.88 (-2.11%)
BSENSE

May 08

BSE+NSE Vol: 66.99 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
2,751.77
2,139.87
2,043.72
1,933.71
2,754.07
2,204.22
2,241.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,751.77
2,139.87
2,043.72
1,933.71
2,754.07
2,204.22
2,241.75
Raw Material Cost
482.59
505.48
483.42
524.35
203.68
805.44
575.14
Purchase of Finished goods
336.03
376.84
374.83
342.83
546.72
161.06
394.77
(Increase) / Decrease In Stocks
237.05
-96.01
-155.75
-173.13
204.58
-160.67
-173.44
Employee Cost
586.02
599.85
611.46
618.59
612.01
556.24
559.53
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
649.57
557.98
571.07
514.37
626.09
504.41
544.14
Total Expenditure (Excl Depreciation)
2,291.26
1,944.14
1,885.03
1,827.01
2,193.08
1,866.48
1,900.14
Operating Profit (PBDIT) excl Other Income
460.51
195.73
158.69
106.70
560.99
337.74
341.61
Other Income
46.06
43.24
65.60
58.40
42.03
12.13
61.11
Operating Profit (PBDIT)
506.57
238.97
224.29
165.10
603.02
349.87
402.72
Interest
82.99
89.24
82.42
86.15
103.68
103.31
107.64
Exceptional Items
-175.77
-41.11
0.00
20.74
0.00
0.00
0.00
Gross Profit (PBDT)
247.81
108.62
141.87
99.69
499.34
246.56
295.08
Depreciation
218.38
212.74
202.84
197.28
242.76
196.81
192.22
Profit Before Tax
43.00
-93.86
-46.18
-79.02
272.80
66.80
120.12
Tax
51.83
42.33
53.04
2.68
119.30
63.12
97.53
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-22.40
-146.45
-114.01
-100.27
137.28
-13.37
5.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-22.40
-146.45
-114.01
-100.27
137.28
-13.37
5.33
Share in Profit of Associates
13.57
10.26
14.79
18.57
16.22
17.05
17.26
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-8.83
-136.19
-99.22
-81.70
153.50
3.68
22.59
Equity Capital
1,327.16
1,325.83
1,325.52
1,324.82
1,323.58
1,323.58
1,323.14
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
-0.07
-1.03
-0.75
-0.62
1.16
0.03
0.17
Diluted Earnings per share
-0.07
-1.03
-0.75
-0.62
1.16
0.03
0.17
Operating Profit Margin (Excl OI)
16.74%
9.15%
7.76%
5.52%
20.37%
15.32%
15.24%
Gross Profit Margin
9.01%
5.08%
6.94%
5.16%
18.13%
11.19%
13.16%
PAT Margin
-0.32%
-6.36%
-4.85%
-4.23%
5.57%
0.17%
1.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 28.60% vs 4.70% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 93.52% vs -37.26% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 135.28% vs 23.34% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -7.00% vs 8.27% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Piramal Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,751.77
432.75
2,319.02
535.88%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,751.77
432.75
2,319.02
535.88%
Raw Material Cost
482.59
183.69
298.90
162.72%
Purchase of Finished goods
336.03
0.00
336.03
(Increase) / Decrease In Stocks
237.05
-19.25
256.30
1,331.43%
Employee Cost
586.02
33.29
552.73
1,660.35%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
649.57
51.51
598.06
1,161.06%
Total Expenditure (Excl Depreciation)
2,291.26
249.24
2,042.02
819.30%
Operating Profit (PBDIT) excl Other Income
460.51
183.51
277.00
150.95%
Other Income
46.06
11.11
34.95
314.58%
Operating Profit (PBDIT)
506.57
194.62
311.95
160.29%
Interest
82.99
1.19
81.80
6,873.95%
Exceptional Items
-175.77
0.00
-175.77
Gross Profit (PBDT)
247.81
193.43
54.38
28.11%
Depreciation
218.38
9.63
208.75
2,167.71%
Profit Before Tax
43.00
183.80
-140.80
-76.61%
Tax
51.83
49.52
2.31
4.66%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-22.40
134.28
-156.68
-116.68%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-22.40
134.28
-156.68
-116.68%
Share in Profit of Associates
13.57
0.00
13.57
Minority Interest
0.00
2.52
-2.52
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-8.83
131.76
-140.59
-106.70%
Equity Capital
1,327.16
40.94
1,286.22
3,141.72%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
-0.07
16.09
-16.16
-100.44%
Diluted Earnings per share
-0.07
16.04
-16.11
-100.44%
Operating Profit Margin (Excl OI)
16.74%
42.41%
0.00
-25.67%
Gross Profit Margin
9.01%
44.70%
0.00
-35.69%
PAT Margin
-0.32%
31.03%
0.00
-31.35%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,751.77 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 28.60% vs 4.70% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -0.08% vs 7.90% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -8.83 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 93.52% vs -37.26% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -105.75% vs 51.57% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 460.51 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 135.28% vs 23.34% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -17.91% vs 5.86% in Mar 2025

Quarterly - Interest
Interest 82.99 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -7.00% vs 8.27% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -19.96% vs -9.23% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.74%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025